1-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-4-[3-(1-methylpyrazol-4-yl)-1H-isoindol-5-yl]pyridin-2-one
C25H18F4N4O — CID 158547244
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-4-[3-(1-methylpyrazol-4-yl)-1H-isoindol-5-yl]pyridin-2-one
1-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-4-[3-(1-methylpyrazol-4-yl)-1H-isoindol-5-yl]pyridin-2-one (PubChem CID 158547244) has the molecular formula C25H18F4N4O and a molecular weight of 466.44 g/mol. Its IUPAC name is 1-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-4-[3-(1-methylpyrazol-4-yl)-1H-isoindol-5-yl]pyridin-2-one.
Molecular Properties
| Compound Name | 1-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-4-[3-(1-methylpyrazol-4-yl)-1H-isoindol-5-yl]pyridin-2-one |
|---|---|
| PubChem CID | 158547244 |
| Molecular Formula | C25H18F4N4O |
| Molecular Weight | 466.44 g/mol |
| Exact Mass | 466.14 |
| IUPAC Name | 1-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]-4-[3-(1-methylpyrazol-4-yl)-1H-isoindol-5-yl]pyridin-2-one |
| SMILES | Cn1cc(C2=NCc3ccc(-c4ccn(Cc5cc(F)cc(C(F)(F)F)c5)c(=O)c4)cc32)cn1 |
| InChI | InChI=1S/C25H18F4N4O/c1-32-14-19(12-31-32)24-22-8-16(2-3-18(22)11-30-24)17-4-5-33(23(34)9-17)13-15-6-20(25(27,28)29)10-21(26)7-15/h2-10,12,14H,11,13H2,1H3 |
| InChIKey | HPGSPYACJJQWNK-UHFFFAOYSA-N |
| XLogP | 4.81 |
| TPSA | 52.18 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.44 |
| LogP ≤ 5 | 4.81 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158547244 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.